Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Shenzhen Stock Exchange 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 672.62 M

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity is USD 672.62 M for the year ending December 31, 2023, a -2.25% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 688.13 M, a -0.57% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 692.07 M, a 1.10% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 684.55 M, a 11.05% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 616.43 M, a 1.34% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shenzhen Stock Exchange: 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

CEO	Mr. Zhi Gang Luo
IPO Date	May 25, 2012
Location	China
Headquarters	No.7 ChangBaiShan Road
Employees	2,333
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Cleaning Supplies Composite Materials Drugstores & Retail Pharmacies Personal Care Plastics

Description

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.

Key trends

Past 5 years